Cancer Research Cancer Research Funding Available  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 339-344, February 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tarnowski, G. S.
Right arrow Articles by Westphal, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tarnowski, G. S.
Right arrow Articles by Westphal, O.

Effect of Lysolecithin and Analogs on Mouse Ascites Tumors1

George S. Tarnowski2, Isabel M. Mountain, C. Chester Stock, Paul G. Munder, Hans U. Weltzien and Otto Westphal

Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [G. S. T., I. M. M., C. C. ¢], and Max Planck-Institut für Immunobiologie, Freiburg-Zähringel, Federal Republic of Germany [P. G. M., H. U. W., O. W.]

Antitumor activity of lysolecithin and its ester and ether analogs has been investigated in three mouse ascites tumors: Meth A, Ehrlich, and Sarcoma S180J. Immediately after mice were inoculated i.p. with a suspension of tumor cells, they were given a single i.p. injection of lysolecithin or an analog. Inhibition of tumor growth was measured as the total packed cell volume on Day 8.

Lysolecithin induced tumor inhibition against Ehrlich and S180J and, to a lesser extent, against Meth A ascites tumor. Further tests with ester-deoxylysolecithin analogs against Meth A showed that derivatives with stearic or lauric acid esters on the C-1 atom of the propanediol moiety induced tumor inhibition to a variable degree. However, the ether analogs, 1-hexadecyl or 1-dodecylpropanediol-3-phosphorylcholines and DL-1,2-dioctylglycero-3-phosphorylcholine, but not the 1-decylpropanediol-3-phosphorycholine, produced more marked, reproducible inhibition.

Detergents, sodium dodecyl sulfate and Hyamine 10-X hydroxide, when injected i.p. immediately after ascites cells, reduced the capacity of the tumor cells to multiply as indicated by lower total packed cell volume on Day 8. Tween 80 did not produce this effect at the same dose. The effect of lysolecithin against the Meth A ascites was observed when treatment was administered 4 days before tumor inoculation but not before that day or subsequently. 1-Hexadecylpropanediol-3-phosphorylcholine was effective when administered as early as 7 days before tumor inoculation or as late as 2 days after.

Treatment with lysolecithin of mice inoculated with 0.5 to 2 x 106 Meth A calls significantly prolonged the median survival time of tumor hosts.

Exposure of ascites cells of Meth A tumor to lysolecithin, 1-hexadecylpropanediol-3-phosphorylcholine, or Hyamine 10-X hydroxide destroyed the cells as shown by trypan blue staining and by reduction of the capacity of the cells to produce tumors on intradermal injection into mice. The concentrations of these substances required to produce a 50% effect were similar over a narrow range. Far higher concentrations of sodium dodecyl sulfate were required for a comparable effect.

1 This work was supported in part by National Cancer Institute Grants CA-08748 and CA-18856-01 and by a grant from the Stiftung Volkswagenwerk.

2 To whom requests for reprints should be addressed.

Received 1/10/77. Accepted 11/ 8/77.




This article has been cited by other articles:


Home page
J R Soc InterfaceHome page
M. Dymond, G. Attard, and A. D Postle
Testing the hypothesis that amphiphilic antineoplastic lipid analogues act through reduction of membrane curvature elastic stress
J R Soc Interface, November 6, 2008; 5(28): 1371 - 1386.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.